Recent advances in diagnosis and treatment of microscopic colitis

RDF 

 
Το τεκμήριο παρέχεται από τον φορέα :
Ελληνική Γαστροεντερολογική Εταιρία
Αποθετήριο :
Annals of Gastroenterology
δείτε την καρτέλα τεκμηρίου
μέσα από τον ιστότοπο του αποθετηρίου του φορέα *
κοινοποιήστε το τεκμήριο



Σημασιολογικός εμπλουτισμός/ομογενοποίηση από το EKT

2011 (EL)
Recent advances in diagnosis and treatment of microscopic colitis (EN)

Wickbom, Anna; Department of Medicine, Division of Gastroenterology, Örebro University Hospital, 70185 Örebro
Eriksson, Sune; Department of Laboratory Medicine, Division of Pathology, Örebro University Hospital, 70185 Örebro
Tysk, Curt; Department of Medicine, Division of Gastroenterology, Örebro University Hospital, 70185 Örebro
Nyhlin, Nils; Department of Medicine, Division of Gastroenterology, Örebro University Hospital, 70185 Örebro
Bohr, Johan; Department of Medicine, Division of Gastroenterology, Örebro University Hospital, 70185 Örebro

Örebro County Research Committee, Örebro University Hospital Research Foundation and the Swedish Society of Medicine (Bengt Ihre Foundation, grants 21142-2008, 22100-2009, 98031-2010) supported our studies of microscopic colitis. (EN)

Microscopic colitis, comprising collagenous colitis and lymphocytic colitis, is a common cause of chronic diarrhoea. It is characterised clinically by chronic watery diarrhoea and a macroscopically normal colonic mucosa where diagnostic histopathological features are seen on microscopic examination. The annual incidence of each disorder is 4-6/100000 inhabitants, with a peak incidence in individuals 60-70 years old and a noticeable female predominance in collagenous colitis. The aetiology is unknown. Chronic diarrhoea, abdominal pain, weight loss, fatigue, and faecal incontinence are common symptoms that impair the health-related quality of life of the patient. There is an association with other autoimmune disorders, such as celiac disease, thyroid disorders, diabetes mellitus, and arthritis. Budesonide is the best-documented treatment, both short-term and long-term. Recurrence of symptoms is common after withdrawal of successful budesonide therapy, and the optimal long-term treatment strategy needs further study. The long-term prognosis is good, and the risk of complications including colonic cancer is low. We review epidemiology, clinical features, diagnosis and treatment of microscopic colitis, (EN)

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Gastroenterologiki Company (EN)

2011-11-15


Annals of Gastroenterology (EN)

Annals of Gastroenterology; Volume 24, No 4 (2011); 253-262 (EN)



*Η εύρυθμη και αδιάλειπτη λειτουργία των διαδικτυακών διευθύνσεων των συλλογών (ψηφιακό αρχείο, καρτέλα τεκμηρίου στο αποθετήριο) είναι αποκλειστική ευθύνη των αντίστοιχων Φορέων περιεχομένου.